Jane Street
CAPR icon

Jane Street’s Capricor Therapeutics CAPR Stock Holding History

Jane Street’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.05M Sell
43,700
-92,700
-68% -$2.81M ﹤0.01% 6437
2026
Q1 		$4.15M Buy
136,400
+70,800
+108% +$1.89M ﹤0.01% 3787
2025
Q4 		$1.89M Sell
65,600
-52,200
-44% -$682K ﹤0.01% 4916
2025
Q3 		$849K Buy
117,800
+39,500
+50% +$291K ﹤0.01% 6678
2025
Q2 		$778K Buy
78,300
+5,700
+8% +$60.2K ﹤0.01% 6075
2025
Q1 		$689K Buy
72,600
+35,400
+95% +$491K ﹤0.01% 6269
2024
Q4 		$513K Buy
37,200
+26,800
+258% +$470K ﹤0.01% 6725
2024
Q3 		$158K Buy
+10,400
New +$51.4K ﹤0.01% 8790

Other funds holding CAPR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jane Street's CAPR Position: Q2 2026 in Review

Jane Street sold out of Capricor Therapeutics (CAPR) in Q2 2026, closing a stake of 566,081 shares — an estimated $17.2M sold.

Jane Street first reported a position in CAPR in Q3 2017 and held it in 12 quarters. The position peaked at $17.2M in Q1 2026. 170 funds tracked by Wall St. Rank hold CAPR as of Q2 2026.

  • Jane Street reported no remaining Capricor Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Jane Street sold 566,081 Capricor Therapeutics shares in Q2 2026, an estimated $17.2M.
  • Jane Street first reported a position in Capricor Therapeutics in Q3 2017 and held it in 12 quarters.
  • Jane Street's Capricor Therapeutics position peaked at $17.2M in Q1 2026.
  • 170 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.